.png)
Expert Insights: Unlocking next generation gene therapies

Assessing cardiotoxicity of a highly selective novel MCL1 inhibitor with iPSC-derived models
.png)
Expert Insights: From animal to iPSC-derived models, a new era in preclinical evaluation
-1.png)
The status of drug discovery and development for Parkinson's disease

Uncovering ALS pathology and potential drug targets with in vitro iPSC models
-1.png)
The status of drug discovery and development for Alzheimer's disease